LKFTLakefront Biotherapeutics NV

$29.19

Who owns LKFT

89 institutions reported holding LKFT for 2026Q1, together 48% of the company, fewer than the 91 a quarter earlier.

89

Institutions reporting a position · as of 2026Q1 · down from 91 the quarter before

Shares held by institutions
31.3M

Shares held by institutions · 48% of the company · long US equity positions only, as reported on Form 13F

Reported value
$938M

Reported value · at 2026-03-31 prices, not today's

Top 5 holders
40%

Top 5 holders · of the whole company, between five filers

Details
Reporting quarter2026-03-31
2026Q1
Quarters on record
44
New positions
16
Positions exited
18
Added to
33
Reduced
27
Top 10 holdersof the company
44%
Institutional ownership by quarter, 2015Q2 to 2026Q1
QuarterFilersSharesReported value
2026Q18931.3M$938M
2025Q49131.4M$1.03B
2025Q39231.4M$1.09B
2025Q28531.7M$887M
2025Q18231.2M$783M
2024Q48131.1M$857M
2024Q37813.7M$393M
2024Q28519.9M$494M
2024Q18120.5M$660M
2023Q48819.8M$804M
2023Q37219.2M$662M
2023Q27519.7M$801M
2023Q17418.2M$704M
2022Q47413.2M$585M
2022Q38312.9M$551M
2022Q28012.9M$720M
Largest reported holders, 2026Q1
HolderShares% of companyValue
GILEAD SCIENCES, INC.16.7M25%$501M
TANG CAPITAL MANAGEMENT LLC3.8M5.8%$114M
Madison Avenue Partners, LP2.5M3.7%$74M
EcoR1 Capital, LLC1.7M2.5%$50M
Prosight Management, LP1.6M2.4%$47M
AMERIPRISE FINANCIAL INC1.4M2.2%$43M
DME Capital Management, LP0.5M0.73%$14M
SEGALL BRYANT & HAMILL, LLC0.4M0.65%$13M
Point72 Asset Management, L.P.0.3M0.51%$10.0M
RENAISSANCE TECHNOLOGIES LLC0.3M0.48%$9.5M

SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.

reading the register…